Back to HALO
OPPENHEIMER ASSET MANAGEMENT INC. → HALO
OPPENHEIMER ASSET MANAGEMENT INC. HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
13
Latest value
$3.3M
Q3 2026
Peak value
$3.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.1M |
| Q3 2025 | $1.1M |
| Q4 2025 | $1M |
| Q4 2025 | $964K |
| Q1 2026 | $993K |
| Q1 2026 | $918K |
| Q2 2026 | $1.2M |
| Q2 2026 | $1.1M |
| Q3 2026 | $128K |
| Q3 2026 | $1.9M |
| Q3 2026 | $171K |
| Q3 2026 | $1.4M |
| Q3 2026 | $3.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.3M | 29.6K | — | — |
| Q3 2026 | $1.4M | 12.9K | — | — |
| Q3 2026 | $171K | 1.5K | — | — |
| Q3 2026 | $1.9M | 17.6K | — | — |
| Q3 2026 | $128K | 1.2K | — | — |
| Q2 2026 | $1.1M | 14.0K | — | — |
| Q2 2026 | $1.2M | 15.1K | — | — |
| Q1 2026 | $918K | 14.2K | — | — |
| Q1 2026 | $993K | 15.4K | — | — |
| Q4 2025 | $964K | 14.3K | — | — |
| Q4 2025 | $1M | 14.9K | — | — |
| Q3 2025 | $1.1M | 15.7K | — | — |
| Q3 2025 | $1.1M | 15.4K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M